Trask OJ - Search Results

1

Development of an in vitro high content imaging assay for quantitative assessment of CAR-dependent mouse, rat, and human primary hepatocyte proliferation.

Soldatow V, Peffer RC, Trask OJ, Cowie DE, Andersen ME, LeCluyse E, Deisenroth C. Soldatow V, et al. Among authors: trask oj. Toxicol In Vitro. 2016 Oct;36:224-237. doi: 10.1016/j.tiv.2016.08.006. Epub 2016 Aug 12. Toxicol In Vitro. 2016. PMID: 27530964

2

A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysis.

Trask OJ Jr, Moore A, LeCluyse EL. Trask OJ Jr, et al. Assay Drug Dev Technol. 2014 Jan-Feb;12(1):16-27. doi: 10.1089/adt.2013.525. Epub 2014 Jan 20. Assay Drug Dev Technol. 2014. PMID: 24444127

3

Assessing dose-dependent differences in DNA-damage, p53 response and genotoxicity for quercetin and curcumin.

Sun B, Ross SM, Trask OJ, Carmichael PL, Dent M, White A, Andersen ME, Clewell RA. Sun B, et al. Among authors: trask oj. Toxicol In Vitro. 2013 Sep;27(6):1877-87. doi: 10.1016/j.tiv.2013.05.015. Epub 2013 Jun 11. Toxicol In Vitro. 2013. PMID: 23764886

4

miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture Model.

Mosedale M, Eaddy JS, Trask OJ Jr, Holman NS, Wolf KK, LeCluyse E, Ware BR, Khetani SR, Lu J, Brock WJ, Roth SE, Watkins PB. Mosedale M, et al. Among authors: trask oj jr. Toxicol Sci. 2018 Jan 1;161(1):149-158. doi: 10.1093/toxsci/kfx206. Toxicol Sci. 2018. PMID: 29029277 Free PMC article.

5

Profiling dose-dependent activation of p53-mediated signaling pathways by chemicals with distinct mechanisms of DNA damage.

Clewell RA, Sun B, Adeleye Y, Carmichael P, Efremenko A, McMullen PD, Pendse S, Trask OJ, White A, Andersen ME. Clewell RA, et al. Among authors: trask oj. Toxicol Sci. 2014 Nov;142(1):56-73. doi: 10.1093/toxsci/kfu153. Epub 2014 Jul 30. Toxicol Sci. 2014. PMID: 25078064 Free PMC article.

6

High-content screening assay for activators of the Wnt/Fzd pathway in primary human cells.

Borchert KM, Galvin RJ, Frolik CA, Hale LV, Halladay DL, Gonyier RJ, Trask OJ, Nickischer DR, Houck KA. Borchert KM, et al. Among authors: trask oj. Assay Drug Dev Technol. 2005 Apr;3(2):133-41. doi: 10.1089/adt.2005.3.133. Assay Drug Dev Technol. 2005. PMID: 15871688

7

Standardization of high content imaging and informatics.

Trask OJ Jr, Johnston PA. Trask OJ Jr, et al. Assay Drug Dev Technol. 2015 Sep;13(7):341-6. doi: 10.1089/adt.2015.29022.ojt. Assay Drug Dev Technol. 2015. PMID: 26317882 Free PMC article. No abstract available.

8

Introduction and welcome to the Society of Biomolecular Imaging and Informatics (SBI²).

Trask OJ, Johnston PA. Trask OJ, et al. Assay Drug Dev Technol. 2014 Sep;12(7):369-74. doi: 10.1089/adt.2014.1506. Assay Drug Dev Technol. 2014. PMID: 25181409 No abstract available.

9

Screening for activators of the wingless type/Frizzled pathway by automated fluorescent microscopy.

Borchert KM, Sells Galvin RJ, Hale LV, Trask OJ, Nickischer DR, Houck KA. Borchert KM, et al. Among authors: trask oj. Methods Enzymol. 2006;414:140-50. doi: 10.1016/S0076-6879(06)14009-4. Methods Enzymol. 2006. PMID: 17110191

10

Generation and characterization of a stable MK2-EGFP cell line and subsequent development of a high-content imaging assay on the Cellomics ArrayScan platform to screen for p38 mitogen-activated protein kinase inhibitors.

Williams RG, Kandasamy R, Nickischer D, Trask OJ Jr, Laethem C, Johnston PA, Johnston PA. Williams RG, et al. Among authors: trask oj jr. Methods Enzymol. 2006;414:364-89. doi: 10.1016/S0076-6879(06)14021-5. Methods Enzymol. 2006. PMID: 17110203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters